Dolutegravir Use at Conception - Additional Surveillance Data from Botswana.

Autor: Raesima MM; Botswana Ministry of Health and Wellness, Gaborone, Botswana., Ogbuabo CM; Botswana-University of Maryland School of Medicine Health Initiative, Gaborone, Botswana., Thomas V; Centers for Disease Control and Prevention, Gaborone, Botswana cqi6@cdc.gov., Forhan SE; Centers for Disease Control and Prevention, Atlanta, GA., Gokatweng G; Botswana-University of Maryland School of Medicine Health Initiative, Gaborone, Botswana., Dintwa E; Botswana Ministry of Health and Wellness, Gaborone, Botswana., Petlo C; Botswana Ministry of Health and Wellness, Gaborone, Botswana., Motswere-Chirwa C; Centers for Disease Control and Prevention, Gaborone, Botswana., Rabold EM; Centers for Disease Control and Prevention, Atlanta, GA., Tinker SC; Centers for Disease Control and Prevention, Atlanta, GA., Odunsi S; Peace Corps, Gaborone, Botswana., Malima S; Botswana Ministry of Health and Wellness, Gaborone, Botswana., Mmunyane O; Botswana Ministry of Health and Wellness, Gaborone, Botswana., Modise T; Botswana Ministry of Health and Wellness, Gaborone, Botswana., Kefitlhile K; Botswana Ministry of Health and Wellness, Gaborone, Botswana., Dare K; Centers for Disease Control and Prevention, Gaborone, Botswana., Letebele M; Centers for Disease Control and Prevention, Gaborone, Botswana., Roland ME; Centers for Disease Control and Prevention, Gaborone, Botswana., Moore CA; Centers for Disease Control and Prevention, Atlanta, GA., Modi S; Centers for Disease Control and Prevention, Atlanta, GA., Williamson DM; Centers for Disease Control and Prevention, Atlanta, GA.

Publikováno v: The New England journal of medicine [N Engl J Med] 2019 Aug 29; Vol. 381 (9), pp. 885-887. Date of Electronic Publication: 2019 Jul 22.